Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AKTS

Aktis Oncology Inc

22.62

Aug 04 • 10:03 AM ET +0.40 (1.78%)

Healthcare Biotechnology USA Small NASD

Peers: IDYA RCUS TNGX CGON KYMR NUVL BMRN RYTM INCY KRYS

| Held by: VTI IWM VXF VTWO IWO SCHA IWN YALL ITOT VTWG

Scroll to Statements

Index	RUT
Market Cap	1.25B
Enterprise Value	723.75M
Income	-
Sales	-
Book/sh	9.16
Cash/sh	9.74
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	79
IPO	Jan 09, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	2.47
P/C	2.32
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	19.49
Current Ratio	19.49
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-
EPS next Y	-2.09
EPS next Q	-0.43
EPS this Y	97.92%
EPS next Y	-28.30%
EPS next 5Y	67.55%
EPS past 3/5Y	-47.94% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	May 11 AMC
EPS/Sales Surpr.	-4.76% 67.20%

Insider Own	42.48%
Insider Trans	-0.46%
Inst Own	46.03%
Inst Trans	84.23%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-8.11%
SMA50	-5.84%
SMA200	8.18%
Trades

Shs Outstand	53.40M
Shs Float	31.79M
Short Float	11.77%
Short Ratio	10.74
Short Interest	3.74M
52W High	34.19 -33.83%
52W Low	14.72 53.70%
Volatility	6.40% 7.73%
ATR (14)	1.72
RSI (14)	42.25
Beta	-
Rel Volume	0.66
Avg Volume	348.40K
Volume	30,208

Perf Week	-1.50%
Perf Month	-14.82%
Perf Quarter	19.08%
Perf Half Y	2.93%
Perf YTD	-16.20%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	34.38
Prev Close	22.23
Price	22.62
Change	1.78%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)